PL141275B1 - Method of obtaining novel n-/3-trifluoromethylphenyl/-n'-propargylpiperazine - Google Patents

Method of obtaining novel n-/3-trifluoromethylphenyl/-n'-propargylpiperazine Download PDF

Info

Publication number
PL141275B1
PL141275B1 PL1984246418A PL24641884A PL141275B1 PL 141275 B1 PL141275 B1 PL 141275B1 PL 1984246418 A PL1984246418 A PL 1984246418A PL 24641884 A PL24641884 A PL 24641884A PL 141275 B1 PL141275 B1 PL 141275B1
Authority
PL
Poland
Prior art keywords
trifluoromethylphenyl
prepared
propargylpiperazine
compound
reaction
Prior art date
Application number
PL1984246418A
Other languages
English (en)
Polish (pl)
Other versions
PL246418A1 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of PL246418A1 publication Critical patent/PL246418A1/xx
Publication of PL141275B1 publication Critical patent/PL141275B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
PL1984246418A 1983-02-28 1984-02-27 Method of obtaining novel n-/3-trifluoromethylphenyl/-n'-propargylpiperazine PL141275B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306964 DE3306964A1 (de) 1983-02-28 1983-02-28 Neues n-arylpiperazin und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
PL246418A1 PL246418A1 (en) 1985-07-02
PL141275B1 true PL141275B1 (en) 1987-07-31

Family

ID=6192038

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1984246418A PL141275B1 (en) 1983-02-28 1984-02-27 Method of obtaining novel n-/3-trifluoromethylphenyl/-n'-propargylpiperazine

Country Status (25)

Country Link
US (1) US4699910A (en:Method)
EP (1) EP0117531B1 (en:Method)
JP (1) JPS59210074A (en:Method)
KR (1) KR910005413B1 (en:Method)
AT (1) ATE22289T1 (en:Method)
AU (1) AU562643B2 (en:Method)
CA (1) CA1240327A (en:Method)
CS (1) CS240997B2 (en:Method)
DD (1) DD218096A5 (en:Method)
DE (2) DE3306964A1 (en:Method)
DK (1) DK158729C (en:Method)
ES (7) ES530073A0 (en:Method)
FI (1) FI77658C (en:Method)
GB (1) GB2135997B (en:Method)
GR (1) GR79822B (en:Method)
HU (1) HU190546B (en:Method)
IE (1) IE56938B1 (en:Method)
IL (1) IL71068A (en:Method)
NO (1) NO158803C (en:Method)
NZ (1) NZ207289A (en:Method)
PH (1) PH21982A (en:Method)
PL (1) PL141275B1 (en:Method)
PT (1) PT78155B (en:Method)
SU (1) SU1223844A3 (en:Method)
ZA (1) ZA841418B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03176457A (ja) * 1989-12-04 1991-07-31 Nippon Paint Co Ltd 新規プロパルギル化合物、その製法ならびに該化合物を含む被覆材
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
US5661163A (en) 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
KR20150013476A (ko) 2012-04-04 2015-02-05 아이백스 인터내셔널 게엠베하 조합요법용 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993899A (en) * 1958-03-31 1961-07-25 Miles Lab Acetylenically unsaturated piperazine derivatives
NL6607959A (en:Method) * 1965-06-10 1966-12-12
DE1545561A1 (de) * 1965-08-23 1969-12-11 Acraf Verfahren zur Herstellung von pharmakologisch aktiven N,N-disubstituierten 1-Aryl-3-aminopropinen
FR2187311B1 (en:Method) * 1972-06-02 1975-06-20 Bouchara Emile
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4180574A (en) * 1978-12-26 1979-12-25 Abbott Laboratories Certain ovicidal piperazines
US4518712A (en) * 1980-06-30 1985-05-21 Taiho Pharmaceutical Company Limited Piperazine derivative and analgesic composition containing the same

Also Published As

Publication number Publication date
ZA841418B (en) 1985-11-27
CS240997B2 (en) 1986-03-13
NO158803B (no) 1988-07-25
IE56938B1 (en) 1992-02-12
ES8603445A1 (es) 1985-12-16
ES536415A0 (es) 1985-12-16
PH21982A (en) 1988-05-02
US4699910A (en) 1987-10-13
KR840007875A (ko) 1984-12-11
ES536412A0 (es) 1985-10-16
SU1223844A3 (ru) 1986-04-07
FI77658C (fi) 1989-04-10
KR910005413B1 (ko) 1991-07-29
PL246418A1 (en) 1985-07-02
AU562643B2 (en) 1987-06-18
NO158803C (no) 1988-11-09
ATE22289T1 (de) 1986-10-15
DE3460733D1 (en) 1986-10-23
DK102084A (da) 1984-08-29
GR79822B (en:Method) 1984-10-31
EP0117531A1 (de) 1984-09-05
PT78155B (de) 1986-07-17
HU190546B (en) 1986-09-29
FI840743L (fi) 1984-08-29
EP0117531B1 (de) 1986-09-17
CS127484A2 (en) 1985-06-13
DK158729C (da) 1990-11-19
NO840732L (no) 1984-08-29
DE3306964A1 (de) 1984-09-06
ES8601174A1 (es) 1985-10-16
GB2135997A (en) 1984-09-12
ES8601173A1 (es) 1985-10-16
AU2508584A (en) 1984-09-06
ES536414A0 (es) 1985-12-16
IL71068A0 (en) 1984-05-31
JPH056545B2 (en:Method) 1993-01-26
JPS59210074A (ja) 1984-11-28
CA1240327A (en) 1988-08-09
ES8603446A1 (es) 1985-12-16
IL71068A (en) 1988-05-31
GB2135997B (en) 1986-02-19
ES8603444A1 (es) 1985-12-16
ES8504754A1 (es) 1985-04-16
DK102084D0 (da) 1984-02-24
ES536413A0 (es) 1985-12-16
PT78155A (de) 1984-03-01
ES536416A0 (es) 1985-12-16
ES8603447A1 (es) 1985-12-16
DD218096A5 (de) 1985-01-30
NZ207289A (en) 1986-07-11
DK158729B (da) 1990-07-09
GB8405113D0 (en) 1984-04-04
ES536411A0 (es) 1985-10-16
FI77658B (fi) 1988-12-30
IE840460L (en) 1984-08-28
FI840743A0 (fi) 1984-02-23
ES530073A0 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
DE602004012564T2 (de) Chinolin- und chinazolinderivate mit affinität für rezeptoren vom 5ht1-typ
EP1326832B1 (en) Chemical compounds
PT99135B (pt) Processo para a preparacao de derivados de piperazina
US3635976A (en) 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
US4427676A (en) Thiomorpholine derivatives
DE3786118T2 (de) Aminoalkylthio-Triazolopyridin- oder Triazolochinolinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel, brauchbar als Antalgikum.
Ager et al. Separation of morphinelike effects by optical resolution. Levo isomers as strong analgetics and narcotic antagonists
DE2037852C3 (de) Neue Piperazinderivate und Verfahren zu ihrer Herstellung
PL141275B1 (en) Method of obtaining novel n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
DE3407955A1 (de) Arzneimittel, enthaltend quartaere 3,4-dihydroisochinoliniumsalze
DE69207301T2 (de) Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde
CA1247098A (en) Antihypertensive 1-piperazine-3-(4-fluorophenyl)- indane derivatives
DE2702537A1 (de) Neue piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP2539706B1 (en) Arylpiperazine opioid receptor antagonists
US3461120A (en) N-((1-piperidyl)-lower-alkyl)-n-((3-,2-,and 1-indolyl)-lower-alkyl) amines
SU927111A3 (ru) Способ получени оксимэфиров или их солей
CN1884262B (zh) 4-氨基哌啶类化合物及其医药用途
US3629266A (en) (phenyl piperidino alkyl)3 4-dihydrocarbostyrils
US3573310A (en) 1-substituted derivatives of 2-indolinone
DE69024385T2 (de) Verbindung zur Behandlung von Störungen des Neurotransmittersystems im Gehirn
WO2001072303A1 (en) Selective ligands for the delta opioid receptor
US3325500A (en) Mono- and bis-[(1-piperidyl)-loweralkyl]amines
WO1992006958A1 (en) 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
US3262936A (en) Ring substituted-1-cyanolower-alkylpiperidines
EP0040947A1 (en) Use of guanidines for manufacturing antidiarrhoeal medicaments and antidiarrhoeal compositions containing these guanidines